Perrigo Makes Softgel Move As Mylan Continues Takeover Play
This article was originally published in The Tan Sheet
Executive Summary
Acquiring Patheon’s Mexico plant not only adds softgel capabilities to Perrigo’s operations but also boosts its value as an acquisition target. The firm continues integrating Omega Pharma’s operations and managing its OTC private label and other businesses as Mylan presses for Perrigo shareholders to consider its bid.